From the Journals

Review supports continued mask-wearing in health care visits


 

FROM ANNALS OF INTERNAL MEDICINE

A new study urges people to continue wearing protective masks in medical settings, even though the U.S. public health emergency declaration around COVID-19 has expired.

Masks continue to lower the risk of catching the virus during medical visits, according to the study, published in Annals of Internal Medicine. And there was not much difference between wearing surgical masks and N95 respirators in health care settings.

The researchers reviewed 3 randomized trials and 21 observational studies to compare the effectiveness of those and cloth masks in reducing COVID-19 transmission.

“Masking in interactions between patients and health care personnel should continue to receive serious consideration as a patient safety measure,” Tara N. Palmore, MD, of George Washington University, Washington, and David K. Henderson, MD, of the National Institutes of Health, Bethesda, Md., wrote in an opinion article accompanying the study.

“In our enthusiasm to return to the appearance and feeling of normalcy, and as institutions decide which mitigation strategies to discontinue, we strongly advocate not discarding this important lesson learned for the sake of our patients’ safety,” Dr. Palmore and Dr. Henderson wrote.

Surgical masks limit the spread of aerosols and droplets from people who have the flu, coronaviruses or other respiratory viruses, CNN reported. And while masks are not 100% effective, they substantially lower the amount of virus put into the air via coughing and talking.

The study said one reason people should wear masks to medical settings is because “health care personnel are notorious for coming to work while ill.” Transmission from patient to staff and staff to patient is still possible, but rare, when both are masked.

The review authors reported no conflicts of interest. Dr. Palmore has received grants from the NIH, Rigel, Gilead, and AbbVie, and Dr. Henderson is a past president of the Society for Healthcare Epidemiology of America.

A version of this article first appeared on WebMD.com.

Recommended Reading

CDC backs FDA’s call for second COVID booster for those at high risk
Journal of Clinical Outcomes Management
Trial shows some relief for long COVID fatigue, researchers say
Journal of Clinical Outcomes Management
Explanation proposed for long-COVID symptoms in the CNS
Journal of Clinical Outcomes Management
Diagnosis by dog: Canines detect COVID in schoolchildren with no symptoms
Journal of Clinical Outcomes Management
Long-COVID patients respond differently to COVID vaccines
Journal of Clinical Outcomes Management
Researchers seek to understand post-COVID autoimmune disease risk
Journal of Clinical Outcomes Management
New drugs in primary care: Lessons learned from COVID-19
Journal of Clinical Outcomes Management
Study of hospitalizations in Canada quantifies benefit of COVID-19 vaccine to reduce death, ICU admissions
Journal of Clinical Outcomes Management
Clinical trials: Top priority for long COVID
Journal of Clinical Outcomes Management
CDC cuts back hospital data reporting on COVID
Journal of Clinical Outcomes Management